Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more

Recent & Breaking News (NDAQ:ANIP)

ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL

PR Newswire February 12, 2020

ANI Announces Launch of Tolterodine Extended-Release Capsules

PR Newswire January 24, 2020

ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP

PR Newswire January 16, 2020

ANI Announces Launch of Paliperidone Extended-Release Tablets

PR Newswire January 14, 2020

ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.

PR Newswire January 9, 2020

ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL

PR Newswire December 18, 2019

ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference

PR Newswire November 26, 2019

ANI Pharmaceuticals Reports Third Quarter Results

PR Newswire November 6, 2019

ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias

PR Newswire October 31, 2019

ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2019 Financial Results

PR Newswire October 30, 2019

ANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business

PR Newswire October 29, 2019

ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study

PR Newswire October 3, 2019

ANI Pharmaceuticals Announces Launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg

PR Newswire October 2, 2019

ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL

PR Newswire September 11, 2019

ANI Pharmaceuticals Reports Second Quarter Results

PR Newswire August 7, 2019

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results

PR Newswire July 31, 2019

ANI Pharmaceuticals Announces Launch of Ranitidine Capsules

PR Newswire June 25, 2019

ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml

PR Newswire June 20, 2019

ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.

PR Newswire June 18, 2019

ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference

PR Newswire June 12, 2019